Search

PremiumRGNX

We identified an unimaginable 350% upside in the biotechnology sector

For RGNX, Stifel Nicolaus analysts issued a dramatic statement with a price target of $40.

By the SpyStocks desk · 5mo ago · 1 min read

The rest of this story is for members

The rest is for members

The story continues: the full timeline, the transaction ranges, and the names the forms carry.

Sign in to keep reading Join the channel

Premium comes through the Telegram channel. Already have a code? Sign in to activate it.

Telegram@TheAmericanDream5

Hot stock alerts, straight to Telegram

Real-time buys, sweeps, and trading halts from the desk. Free to join.

Join the channel

Related Stories

Three analysts and AI industry experts re-rate Nvidia - we've compiled everything important for you to know

AnalystsNVDA1d ago5 min read

AnalystsNVDA

Three analysts and AI industry experts re-rate Nvidia - we've compiled everything important for you to know

1d ago · 5 min

KURA: buy recommendation from analysts

PremiumAnalystsKURA1w ago1 min read

AnalystsPremiumKURA

KURA: buy recommendation from analysts

1w ago · 1 min

Onds: Oppenheimer raises price target

PremiumAnalystsONDS1w ago1 min read

AnalystsPremiumONDS

Onds: Oppenheimer raises price target

1w ago · 1 min